The development of retention time prediction model using multilinear gradient profiles of seven pharmaceuticals-Reference-Cited by-同舟云学术

The development of retention time prediction model using multilinear gradient profiles of seven pharmaceuticals

Published:2021-05 Issue: Volume:198 Page:114024
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Kitamura Ryunosuke^ORCID,Kawabe Takefumi,Kajiro Toshi,Yonemochi Etsuo

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference31 articles.

1. Pharmaceutical cGMPs for the 21st Century – A Risk-Based Approach, Final Report,2004

2. A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603);Gavin;J. Pharm. Biomed. Anal.,2008

3. ICH Harmonized Tripartite Guideline, Pharmaceutical Development,2009

4. ICH Harmonized Tripartite Guideline, Development and Manufacture of Drug Substances (Chemical Entities and biotechnological/biological Entities),2012

5. Guidelines from the international conference on harmonisation (ICH), S.K. Branch;J. Pharm. Biomed. Anal.,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for hemoglobin decline in gastric cancer patients undergoing postoperative chemotherapy: a retrospective analysis;American Journal of Translational Research;2024

2. Retention Time Prediction with Message-Passing Neural Networks;Separations;2022-10-06

3. Development of a retention prediction model in ion-pair reversed-phase HPLC for nucleoside triphosphates used as mRNA vaccine raw materials;Journal of Chromatography B;2022-03